Secondary Logo

Small-Incision Femtosecond Laser–Assisted Intracorneal Concave Lenticule Implantation in Patients With Keratoconus

Jin, He, PhD, MD*,†; He, Miao, PhD, MD*; Liu, Hongshan, PhD, MD; Zhong, Xiaoying, MD§; Wu, Junshu, PhD, MD*; Liu, Liangping, PhD, MD*; Ding, Hui, PhD, MD; Zhang, Chi, PhD, MD*; Zhong, Xingwu, PhD, MD*,‡

doi: 10.1097/ICO.0000000000001877
Clinical Science
Open
SDC

Purpose: To evaluate the feasibility and efficacy of small-incision femtosecond laser–assisted intracorneal concave lenticule implantation (SFII) and penetrating keratoplasty (PKP) in patients with progressive keratoconus.

Methods: All the patients were clinically diagnosed with progressive keratoconus. Twenty patients underwent PKP (PKP group), and 11 patients underwent SFII (SFII group). Visual acuity, intraocular pressure, corneal topography, corneal visualization Scheimpflug technology, anterior segment optical coherence tomography, and in vivo confocal microscopy were analyzed.

Results: Vision improved at 3 months postoperatively in the SFII group. In the PKP group, corrected distance visual acuity improved 1 week after surgery. Corneal topography showed a statistically significant decrease in the anterior K1 and K2. Corneal visualization Scheimpflug technology showed that changes in the biomechanical parameters of the SFII group were also statistically different from those of the PKP group. All the grafts from both groups were clearly visible by anterior segment optical coherence tomography observation. The central corneal thickness of both groups was stable during the 24-month study period. In vivo confocal microscopy showed a few dendritic cells in the subepithelial region in the SFII group. At 3 months after surgery, many dendritic cells and inflammatory cells were observed in the basal epithelium and stroma in the PKP group.

Conclusions: Both SFII and PKP surgical procedures resulted in a stable corneal volume and improved visual acuity in this long-term study. SFII was less invasive and more efficient compared with PKP.

*State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China;

Hainan Eye Hospital and Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Haikou, China;

Affiliated Hospital of Guilin Medical University, Guilin Medical University, Guilin, China; and

§Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada.

Correspondence: Xingwu Zhong, PhD, MD, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, SunYat-sen University. Guangzhou 510060, China. (e-mail: zhongxwu@mail.sysu.edu.cn).

Supported by grants from the National Natural Science Foundation of China (81870681), the National Natural Science Foundation of China for Youth (81500755), and the Natural Science Foundation of Hainan Province (2017CXTD011, 817365).

The authors have no conflicts of interest to disclose.

All authors made substantial contributions to conception and design. H. Jin, L. Liu, X. Zhong, and M. He collected the data. J. Wu, H. Liu, H. Ding, and C. Zhang made substantial contributions to analysis and interpretation of data. He Jin wrote the first draft of the manuscript. All authors were involved in revising the manuscript critically for important intellectual content. X. Zhong has given final approval of the version to be published. All authors read and approved the final manuscript.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.corneajrnl.com).

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Received August 11, 2018

Received in revised form December 06, 2018

Accepted December 07, 2018

Keratoconus is a proinflammatory corneal disease that is characterized by progressive corneal ectasia and steepening resulting from central corneal thinning.1 It has an incidence of 0.05%, with an age range of 9 to 28 years.2–4 At present, the main operative corrections for keratoconus are corneal collagen cross-linking (CXL) therapy and corneal transplantation. Collagen cross-linking therapy5 increases the biomechanical stability of the cornea.6–8 However, halting progression resulting from corneal collagen cross-linking may only be transient.9 Penetrating keratoplasty (PKP) is usually the preferred treatment to improve visual acuity.10–12 Nevertheless, the graft survival rate reduces with time postoperatively from 98% to 86% between 1 and 20 years postoperatively, respectively.13,14

Corneal intrastromal implantation was first described by Barraquer.15 This inlay model does not affect the integrity of the corneal epithelium or endothelium. However, clinical application of this model is limited because of its invasiveness during creation of the intrastromal pocket and poor inlay materials.15 In a previous study,16,17 we have shown that there was no implant rejection after autotransplantation or xenotransplantation using a small-incision femtosecond laser–assisted corneal intrastromal implantation procedure in all rhesus monkeys during a 26-month study period. We also found that the modified concave inlay lamellae changed corneal refractive power.18 In studies by Liu et al19 and Liu et al,20 allogeneic lenticules were used to change the refractive power in the animal models. Pradhan et al21 and Ganesh et al22 also found that the meniscus allogeneic lenticule from small incision lenticule extraction (SMILE) could reshape the cornea with the necessary precision to correct hyperopia in the recipient. However, the concave lenticule might have more usage in keratectatic diseases, and the use of this inlay allograft corneal implantation model, assisted by the femtosecond laser, has not been explored in patients with progressive keratoconus.

In the present study, we developed a small-incision femtosecond laser–assisted intracorneal concave lenticule implantation (SFII) procedure to implant the allogeneic corneal lamella in human patients with progressive keratoconus. The feasibility and safety of the allogeneic grafts implanted using SFII and conventional PKP were compared.

Back to Top | Article Outline

MATERIALS AND METHODS

Patients and Study Design

This is a retrospective study design. This interventional case series study was approved by the Ethics Committee of the Hainan Eye Hospital of Zhongshan Ophthalmic Center (Sun Yat-sen University, China). All research followed the tenets of the Declaration of Helsinki. Written informed consent was obtained from all patients after explanation of the nature of the study and potential risks. All patients were diagnosed with keratoconus based on results from slit-lamp microscopy, corneal topography, corneal visualization Scheimpflug technology (CST), and anterior segment optical coherence tomography (AS-OCT). A total of 31 consecutive patients (31 eyes) were enrolled in the study. Inclusion criteria were clinical evidence of progressive keratoconus,23 stage II to III keratoconus based on the Amsler–Krumeich classification system24 intolerance to any type of contact lens, transparent cornea, and normal endothelial cell density for age range. Exclusion criteria were active anterior segment pathologic features, previous corneal or anterior segment surgery, and pregnancy or lactation.

Twenty patients underwent PKP between June 2014 and March 2016 (ethics acceptance number: 2014–008). After obtaining approval from the Ethics Committee (ethics acceptance number: 2016–007), 11 patients underwent SFII between April 2016 and November 2017. Table 1 summarizes the baseline patient data.

TABLE 1

TABLE 1

Back to Top | Article Outline

Surgical Technique

All donor tissues were collected from the Hainan Eye Hospital eye bank in accordance with local guidelines (Hainan Entry-Exit Inspection and Quarantine Bureau of the People's Republic of China).

Back to Top | Article Outline

SFII

The donor cornea was placed into an artificial anterior chamber (AC). A lamellar incision was made using the treatment mode of femtosecond laser–assisted LK (VisuMax; Carl Zeiss Meditec, Jena, Germany); we used the surgical parameters described in our previous research.16 The surgical parameters were as follows: the diameter of the incision was 7.5 mm, and the incision was located at a depth of 320 μm. The next step was myopic correction of −4.00 diopters (69.59 μm thickness) under PRK (Photorefractive Keratectomy type; WaveLight GmbH, Erlangen, Germany). The lenticule was separated from the stromal bed and used as the graft. The anterior–posterior orientation of the inlay was maintained during implantation (320–69.59 = 250.41 μm thickness) (see Supplemental Figure 1, Supplemental Digital Content 1, http://links.lww.com/ICO/A744).

Topical anesthesia consisted of proparacaine hydrochloride eye drops (Alcaine; Alcon Laboratories, Fort Worth, TX). A myopic correction of −0.75 diopters (28 μm thickness) using a femtosecond laser system under SMILE treatment was performed on the recipient cornea. We used the femtosecond laser parameters described in our previous research.16 The surgical parameters were as follows: 160 μm cap thickness, 7.8 mm cap diameter, and 7.8 mm lamellar cornea diameter. The surgeon spread the lenticule out, producing a space that resembles a “stromal pocket” inside the corneal stroma. The graft was implanted into the “stromal pocket” (depth of implantation: 160-μm) (see Video 1, Supplemental Digital Content 3, http://links.lww.com/ICO/A746). Postoperatively, tobramycin and dexamethasone eye drops (Alcon Laboratories, Fort Worth, TX) were administered 4 times per day for 1 month.

Back to Top | Article Outline

PKP

PKP was performed under general anesthesia with the anesthetist's assistance. The center of the host cornea was marked and then completely excised using a Barron vacuum trephine (Katena Products, Denville, NJ). The donor corneas were cut using a punch trephine on a Troutman guide (Medtronic Solan, Jacksonville, FL). All grafts had diameters between 7.0 and 8.0 mm. All grafts were closed with a continuous 24-bite running 10-0 nylon suture.

Postoperatively, patients received tobramycin and dexamethasone eye drops (Alcon Laboratories, Fort Worth, TX) 4 times per day for 3 months and recombinant bovine basic fibroblast growth factor (Fusion Protein, Bausch and Lomb, Rochester, NY) eye gel 3 times per day for 6 months. All eyes in the PKP group were treated with mannitol 1 time postoperatively.

Back to Top | Article Outline

Clinical Examination

Ophthalmic examinations were performed preoperatively and at 1 week, 1 month, 3 months, 6 months, 12 months, and 24 months postoperatively. In the PKP group, the corneal sutures were removed at 12 months postoperatively.

The clinical assessment included preoperative assessment, postoperative ocular response, visual acuity, intraocular pressure (IOP), corneal topography, and corneal strength. The ocular response was assessed by slit-lamp microscopy (Nikon, Tokyo, Japan), ciliary redness (Oculus Keratograph 5M; Oculus Optikgeräte GmbH, Wetzlar, Germany), AS-OCT (DRI Triton OCT; Topcon Corporation, Tokyo, Japan), and in vivo confocal microscopy (HRT III; Heidelberg Engineering GmbH, Heidelberg, Germany). This included eyelid spasm, ciliary flush, corneal clarity and neovascularization, anterior segment imaging, and keratocyte responses. Corneal topography and AC evaluation were recorded using the Pentacam HR Scheimpflug camera (Oculus Optikgeräte GmbH, Wetzler, Germany). Central corneal thickness was measured using AS-OCT. Corneal strength was evaluated by CST (Oculus Optikgeräte GmbH, Wetzler, Germany).

Back to Top | Article Outline

Statistical Analysis

Visual acuity was measured using Snellen charts. For statistical analysis purposes, Snellen visual acuity was converted to the corresponding logarithm of the minimum angle of resolution value using standard conversion tables. Other outcome measures included IOP, ciliary flush grade, keratometry, AC depth, AC volume, corneal posterior maximal elevation, data from CST, and corneal thickness. Statistical analysis was conducted using SPSS 16.0 statistical software (SPSS Inc, Chicago, IL). All measurements are expressed as mean ± SD. All the data above were assessed using one-way analysis of variance. For pairwise comparisons within the group, we used either the least significance difference test or Tamhane T2. P < 0.05 was considered statistically significant.

Back to Top | Article Outline

RESULTS

Complications/Adverse Events

In the PKP group, 1 eye had elevated IOP and graft rejection at 3 months after surgery. This eye had to be removed from this trial.

Back to Top | Article Outline

Visual Acuity and Intraocular Pressure

As shown in Figure 1, in the SFII group, both uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) improved at 3 months postoperatively (P UDVA = 0.004, P CDVA = 0.016) and remained stable thereafter. UDVA did not improve in the PKP group throughout the 24-month period after surgery (P 24m = 0.137), and CDVA improved 1 week after surgery (P 1w = 0.001) and remained stable thereafter. IOP increased in the 1-month follow-up period in the PKP group (P PKP = 0.001), and it declined to the preoperative level at 3 months postoperatively (P PKP-3m = 0.748). In the SFII group, IOP maintained a steady level during the 1-month postoperative period (P SFCII-1m = 0.594) (see Supplemental Figure 2, Supplemental Digital Content 2, http://links.lww.com/ICO/A745).

FIGURE 1

FIGURE 1

Back to Top | Article Outline

Slit-Lamp Microscopy and Ciliary Redness Assessment

Figure 2 summarizes the findings on slit-lamp microscopy in both groups. In the SFII group, with regard to all implants, there were no infections or tissue degradation detected during the long-term study period. No increased ciliary redness or corneal neovascularization was observed. Graft edema greatly subsided after 1 month, and the implant boundary was smooth and visible (Fig. 2). In the PKP group, obvious ciliary redness was observed for 1 week after surgery. Fresh epithelialization occurred at 1 month postoperatively, and the margin of the graft still exhibited evident edema (Fig. 2; see also Supplemental Figure 2, Supplemental Digital Content 2, http://links.lww.com/ICO/A745).

FIGURE 2

FIGURE 2

Back to Top | Article Outline

Pentacam HR Scheimpflug Camera Scanning

Table 2, Table 3, and Figure 3 summarize the corneal topographic changes. Corneal curvature maps (Fig. 3) demonstrate that changes in the corneal surface were different in the two treatment groups. In both groups, the anterior K1 and K2, AC volume, and AC depth were significantly decreased after surgery. However, the corneal posterior K1 and K2 in the SFII group also decreased after surgery, whereas the values in the PKP group had increased at 24 months postoperatively.

Table 2

Table 2

TABLE 3

TABLE 3

FIGURE 3

FIGURE 3

Back to Top | Article Outline

CST

Corneal biomechanics measured after surgery were different from those measured preoperatively, with changes in the SFII group much more obvious than those in the PKP group. The ΔA1L, ΔA1V, ΔA1T, andΔHC time in the SFII group were greater than those in the PKP group. In addition, the ΔA2L, ΔA2V, ΔA2T, ΔMDA, ΔPD, and ΔHC radius in the SFII group were lower than those in the PKP group (Table 4).

TABLE 4

TABLE 4

Back to Top | Article Outline

Corneal Imaging with AS-OCT

In the PKP group, the graft exhibited obvious evidence of edema on AS-OCT at 1 week postoperatively. AS-OCT in the SFII group revealed a clearly visible graft in the corneal stroma. The graft was concave, with its shape thinning centrally and thickening laterally (Fig. 4). In the SFII group, central corneal thickness was greatly increased compared with the preoperative findings. The change in thickness (ΔThickness) is defined as the comparison between the postoperative and preoperative corneal thicknesses. Postoperatively, the ΔThickness in the SFII group did not change until 24 months postoperatively (P 1m = 0.901, P 3m = 0.811, P 6m = 0.785, P 12m = 0.426, and P 24m = 0.450). In the PKP group, the ΔThickness had decreased at 3 months after surgery (P 1w = 0.004, P 1m = 0.001) (see Supplemental Figure 2, Supplemental Digital Content 2, http://links.lww.com/ICO/A745).

FIGURE 4

FIGURE 4

Back to Top | Article Outline

In Vivo Confocal Microscopy

In the SFII group, at 1 month postoperatively, confocal microscopy revealed dendritic cells in the subepithelial region (Fig. 5A). Dendritic and inflammatory cells could be observed at the interface between the graft and the host cornea, and there was an acellular structure with some hyperreflective and polymorphic spots arranged randomly. No dendritic or inflammatory cells were observed 3 months after surgery. The endothelial cells showed no particular change in shape and density during the follow-up period. In the PKP group, numerous dendritic cells and inflammatory cells were dispersed in the basal epithelium and stroma within 3 months after surgery. The endothelial cells had a lower-than-normal endothelial cell density and a higher coefficient of variation (Fig. 5B).

FIGURE 5

FIGURE 5

Back to Top | Article Outline

DISCUSSION

In both groups, corneal curvature remained stable, and both CDVA and UDVA improved until 24 months after surgery. Our findings suggest that these 2 surgical procedures can offer long-term stabilization and improve visual outcomes in those with progressive keratoconus. In the SFII group, the inlay graft was well tolerated, and the outcomes in this group indicate that the SFII procedure is efficient and minimally invasive. The implants in the SFII group were centered in the stromal pocket, which not only changed corneal curvature but also improved corneal strength. The findings of this study suggest that SFII could be a safe and efficient surgical approach, and it might halt progression of keratoconus in further studies.

Compared with PKP, the SFII procedure is minimally invasive. A major advantage of the SFII procedure is that it requires no sutures or blades, which greatly reduces the surgical time.25 Known as the “all-in-one” femtosecond laser technique, this technique allows for molding of implants, a minimal incision of 3.0 mm, and a consistent depth and thickness on every occasion.26 Therefore, this procedure does not involve any intraocular manipulations, and all surgical manipulations can be confined to a pocket within the recipient cornea. After surgery, the implanted grafts were stable with no dislodgement, as confirmed by AS-OCT. Monitoring dendritic cell changes after transplantation could provide information on graft inflammation and a graft-versus-host disease outcome.27 There were a large number of dendritic and inflammatory cells in the eyes undergoing PKP, and it took more time for these to settle. The postoperative inflammatory reaction in the PKP group may have also had a greater influence on IOP postoperatively. In each case from the SFII group, the tear film was normal, and the epithelium and endothelium were intact and healthy. In addition, the dendritic cells remained present for a short period after implantation. In addition, the endothelial cells were found to have undergone no obvious change in the SFII group. Corneal endothelium function recovered earlier than that of the PKP group. This could be the other reason why graft edema resolved faster in the SFII group compared with the PKP group. This indicates that the SFII procedure has a negligible impact on the anterior segment. In addition, this minimally invasive surgical approach could provide a precise intrastromal match between the donor inlay and the recipient.

Corneal curvature completely changed after transplantation in both groups (Fig. 3). In the PKP group, these changes were influenced by the suture and donor cornea. In the SFII group, the implanted graft was concave, as confirmed by AS-OCT (Fig. 4). As showed in Figure 3, anterior mid-peripheral corneal curvature changed more than did anterior central corneal curvature. According to the change in corneal remodeling, we confirmed that the reshaped cornea was relatively thinner centrally and thicker peripherally. Because of greater regularization of the cornea in the SFII group, vision improved more than in the PKP group. This additive implantation procedure not only increased recipient corneal thickness (250.4–28 = 222.4 μm) but also increased the strength of the host cornea, as shown by CST. This increase in strength and remodeling of the host cornea might be more stable and controllable, and it may halt progression of keratoconus in further studies.

Compared with the surgical method performed by Mastropasqua et al,28 who adopted the positive meniscus lenticules from the SMILE procedure to be the allografts and evaluated patients who had stable corneal ectasia, we used concave lenticules in the treatment of progressive keratoconus. Furthermore, Hashemi et al29 found that the corneal shape had a prolate shift, which was a similar finding of the present study. Nevertheless, it should be noted that this ring did not affect corneal thickness and that eyes with severe corneal thinning and steepening may not be eligible for the procedure.30 Bowman layer transplantation has also been shown to be beneficial in reducing ectasia in advanced keratoconus because it is a minimally invasive procedure with few postoperative complications.31 The procedure of the Bowman layer graft needs higher technology requirement and time consuming.32

The present study has its limitations and several potential applications. Because other refractive parameters are less likely to be affected by surgery, the change in corneal refractive power in the SFII group was not only decided by the refractive power of the graft inlayed, but it was also dependent on anterior and posterior deformation of corneal curvature. Further study is needed to evaluate the final corrections of the refractive powers of the inlay. This inlay procedure is an additive surgery, and it still might not improve vision in patients with an obvious corneal scar in some corneal ectatic disorders.

Back to Top | Article Outline

CONCLUSION

Using SFII, we found that the eyes maintained a stable corneal volume, and vision improved during the long-term follow-up period. The SFII procedure may provide a new treatment option for keratoconus in the future. Moreover, this technique may also provide new hope for the treatment of other corneal diseases.

Back to Top | Article Outline

REFERENCES

1. Choi JA, Kim MS. Progression of keratoconus by longitudinal assessment with corneal topography. Invest Ophthalmol Vis Sci. 2012;53:927–935.
2. Collier SA. Is the corneal degradation in keratoconus caused by matrix-metalloproteinases? Clin Exp Ophthalmol. 2001;29:340–344.
3. Wilson SE, Lin DT, Klyce SD. Corneal topography of keratoconus. Cornea. 1991;10:2–8.
4. Zadnik K, Barr JT, Edrington TB, et al. Baseline findings in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Invest Ophthalmol Vis Sci. 1998;39:2537–2546.
5. Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol. 2006;17:356–360.
6. Raiskup-Wolf F, Hoyer A, Spoerl E, et al. Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results. J Cataract Refract Surg.. 2008;34:796–801.
7. Caporossi A, Mazzotta C, Baiocchi S, et al. Long-term results of riboflavin ultraviolet a corneal collagen cross-linking for keratoconus in Italy: the Siena eye cross study. Am J Ophthalmol. 2010;149:585–593.
8. Toprak I, Yaylali V, Yildirim C. Factors affecting outcomes of corneal collagen crosslinking treatment. Eye (Lond). 2014;28:41–46.
9. Brown SE, Simmasalam R, Antonova N, et al. Progression in keratoconus and the effect of corneal cross-linking on progression. Eye Contact Lens. 2014;40:331–338.
10. Kanai A. The pathogenesis and treatment of corneal disorders [in Japanese]. Nippon Ganka Gakkai Zasshi. 2002;106:757–776; discussion 777.
11. Keane M, Coster D, Ziaei M, et al. Deep anterior lamellar keratoplasty versus penetrating keratoplasty for treating keratoconus. Cochrane Database Syst Rev. 2014:CD009700.
12. Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42:297–319.
13. Kelly TL, Coster DJ, Williams KA. Repeat penetrating corneal transplantation in patients with keratoconus. Ophthalmology. 2011;118:1538–1542.
14. Zhang YM, Wu SQ, Yao YF. Long-term comparison of full-bed deep anterior lamellar keratoplasty and penetrating keratoplasty in treating keratoconus. J Zhejiang Univ Sci B. 2013;14:438–450.
15. Barraquer JI. Keratophakia. Trans Ophthalmol Soc U K. 1972;92:499–516.
16. Jin H, Liu L, Ding H, et al. Comparison of femtosecond laser-assisted corneal intrastromal xenotransplantation and the allotransplantation in rhesus monkeys. BMC Ophthalmol. 2017;17:202.
17. Liu L, Wang Y, He M, et al. Preliminary investigation femtosecond laser-assisted refractive lenticule transplantation in rhesus monkeys. J Sunyat-sen Univ (Medical Sciences). 2015;36:449–455.
18. He M, Jin H, He H, et al. Femtosecond laser-assisted small incision endokeratophakia using a xenogeneic lenticule in rhesus monkeys. Cornea. 2018;37:354–361.
19. Liu R, Zhao J, Xu Y, et al. Femtosecond laser-assisted corneal small incision allogenic intrastromal lenticule implantation in monkeys: a pilot study. Invest Ophthalmol Vis Sci. 2015;56:3715–3720.
20. Liu H, Zhu W, Jiang AC, et al. Femtosecond laser lenticule transplantation in rabbit cornea: experimental study. J Refract Surg. 2012;28:907–911.
21. Pradhan KR, Reinstein DZ, Carp GI, et al. Femtosecond laser-assisted keyhole endokeratophakia: correction of hyperopia by implantation of an allogeneic lenticule obtained by SMILE from a myopic donor. J Refract Surg. 2013;29:777–782.
22. Ganesh S, Brar S, Rao PA. Cryopreservation of extracted corneal lenticules after small incision lenticule extraction for potential use in human subjects. Cornea. 2014;33:1355–1362.
23. Giacomin NT, Netto MV, Torricelli AA, et al. Corneal collagen cross-linking in advanced keratoconus: a 4-year follow-up study. J Refract Surg. 2016;32:459–465.
24. Ishii R, Kamiya K, Igarashi A, et al. Correlation of corneal elevation with severity of keratoconus by means of anterior and posterior topographic analysis. Cornea. 2012;31:253–258.
25. Blum M, Täubig K, Gruhn C, et al. Five-year results of small incision lenticule extraction (ReLEx SMILE). Br J Ophthalmol. 2016;100:1192–1195.
26. Xie RZ, Evans MD, Bojarski B, et al. Two-year preclinical testing of perfluoropolyether polymer as a corneal inlay. Invest Ophthalmol Vis Sci. 2006;47:574–581.
27. Killian D, Reichard M, Knueppel A, et al. Distribution changes of epithelial dendritic cells in canine cornea and mucous membranes related to hematopoietic stem cell transplantation. In Vivo. 2013;27:761–771.
28. Mastropasqua L, Nubile M, Salgari N, et al. Femtosecond laser-assisted stromal lenticule addition keratoplasty for the treatment of advanced keratoconus: a preliminary study. J Refract Surg. 2018;34:36–44.
29. Hashemi H, Amanzadeh K, Miraftab M, et al. Femtosecond-assisted intrastromal corneal single-segment ring implantation in patients with keratoconus: a 12-month follow-up. Eye Contact Lens. 2015;41:183–186.
30. Alió JL, Shabayek MH, Belda JI, et al. Analysis of results related to good and bad outcomes of Intacs implantation for keratoconus correction. J Cataract Refract Surg. 2006;32:756–761.
31. Sharma B, Dubey A, Prakash G, et al. Bowman's layer transplantation: evidence to date. Clin Ophthalmol. 2018;12:433–437.
32. Dragnea DC, Birbal RS, Ham L, et al. Bowman layer transplantation in the treatment of keratoconus. Eye Vis (Lond). 2018;5:24.
Keywords:

keratoconus; femtosecond laser; small incision; intracorneal implantation; penetrating keratoplasty

Supplemental Digital Content

Back to Top | Article Outline
Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.